NO link of MMR vaccine to autism – AGAIN

Danish researchers have used 5 025 754 person-years of follow-up to address a long-standing matter of what has been an issue of contention: during the follow-up, 6517 children were diagnosed with autism, at an incidence rate, 129.7 per 100 000 person-years. Comparing...

Beyond deprescribing

In the medicines safety community, one would need to be living under a rock not to have read a great deal about deprescribing by now. Less attention has been devoted to diagnoses, which allow clinicians to make sensible prescribing decisions. In a new slant, the...

Poor CYP2D6 metabolisers might be better to avoid codeine or tramadol

Both tramadol and codeine are CYP2D6 substrates. A recent study has shown that people who are ultrarapid and poor CYP2D6 metabolizers are less liekly normal or indeterminate metabolizers (p = 0.01). After adjusting the CYP2D6 activity score for drug–drug interactions,...

Deprescribing should be incorporated into end of life care

Polypharmacy is often a finding at the end of life. A recent study of adults with advanced, life-limiting illness examined the possible effects of this syndrome upon symptom burden (assessed using the Edmonton Symptom Assessment Scale) and quality of life (assessed...

Sub-optimal statin adherence increases mortality risk

Statin treatment is implemented to decrease mortality amongst people with atherosclerotic cardiovascular disease. Researchers have recently used a very large cohort study to explore the association between statin adherence and mortality in these patients. The primary...